Global Blood Group Typing Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Blood Group Typing Market Size

• The global blood group typing market size was valued at USD 3.85 billion in 2025 and is expected to reach USD 8.13 billion by 2033, at a CAGR of 9.8% during the forecast period
• The market growth is largely fueled by the increasing demand for safe blood transfusions and advancements in diagnostic technologies, leading to improved accuracy and efficiency in blood group identification across healthcare settings
• Furthermore, the rising prevalence of chronic diseases, growing number of surgical procedures, and expanding blood donation initiatives are driving the need for reliable and rapid blood typing solutions. These converging factors are accelerating the adoption of advanced blood group typing systems, thereby significantly boosting the industry's growth

Blood Group Typing Market Analysis

• Blood group typing, involving the identification of blood antigens and antibodies for safe transfusion and transplantation, is a critical component of modern healthcare systems across hospitals, blood banks, and diagnostic laboratories due to its essential role in ensuring compatibility and preventing adverse reactions
• The escalating demand for blood group typing is primarily fueled by the increasing number of surgical procedures, rising prevalence of chronic and blood-related disorders, and growing awareness regarding safe blood transfusion practices
• North America dominated the blood group typing market with the largest revenue share of 38.5% in 2025, characterized by advanced healthcare infrastructure, high adoption of automated diagnostic technologies, and a strong presence of key industry players, with the U.S. witnessing significant demand driven by robust blood donation systems and continuous technological advancements in immunohematology
• Asia-Pacific is expected to be the fastest growing region in the blood group typing market during the forecast period due to expanding healthcare infrastructure, increasing awareness about blood safety, and rising government initiatives to support blood donation programs
• Consumables segment dominated the blood group typing market with a market share of 45.7% in 2025, driven by their recurring usage in routine testing procedures and the growing volume of diagnostic and transfusion-related activities

Report Scope and Blood Group Typing Market Segmentation

Blood Group Typing Market Trends

“Rising Adoption of Automation and Molecular Typing Technologies”

• A significant and accelerating trend in the global blood group typing market is the increasing integration of automation and molecular diagnostic technologies such as PCR and genotyping platforms. This combination of technologies is significantly enhancing testing accuracy and operational efficiency across laboratories
• For instance, automated analyzers from leading companies such as Bio-Rad Laboratories and Grifols enable high-throughput blood typing with minimal manual intervention, improving workflow efficiency and reducing turnaround time. Similarly, molecular typing solutions allow precise antigen detection beyond conventional serology methods
• Automation in blood group typing enables features such as standardized testing procedures, reduced human error, and improved reproducibility of results. For instance, advanced systems can process large sample volumes while maintaining accuracy and consistency in results, and can flag discrepancies in complex cases. Furthermore, molecular techniques provide deeper insights into rare blood group variants and antigen mismatches
• The seamless integration of automated systems with laboratory information systems facilitates centralized data management and real-time tracking of blood samples. Through a unified digital interface, healthcare providers can manage typing results alongside patient records, inventory systems, and transfusion protocols, ensuring improved coordination and patient safety
• This trend towards more precise, scalable, and technology-driven blood typing systems is fundamentally reshaping laboratory practices and transfusion medicine. Consequently, companies such as Ortho Clinical Diagnostics are developing advanced platforms with automation capabilities and molecular compatibility for enhanced testing accuracy and efficiency
• The demand for automated and molecular-based blood group typing solutions is growing rapidly across hospitals, blood banks, and diagnostic laboratories, as healthcare providers increasingly prioritize accuracy, speed, and scalability in transfusion services

Blood Group Typing Market Dynamics

Driver

“Growing Need Due to Increasing Surgical Procedures and Blood Safety Awareness”

• The increasing number of surgical procedures worldwide, coupled with rising awareness regarding safe blood transfusion practices, is a significant driver for the heightened demand for blood group typing solutions
• For instance, in March 2025, Abbott Laboratories announced advancements in automated diagnostic platforms aimed at improving blood screening and transfusion safety. Such strategies by key companies are expected to drive the blood group typing industry growth in the forecast period
• As healthcare systems expand and the burden of chronic and trauma-related conditions rises, accurate blood typing becomes essential to ensure compatibility and prevent transfusion-related complications, thereby strengthening the need for reliable diagnostic solutions
• The rising incidence of trauma cases and emergency care requirements is significantly increasing the demand for rapid and accurate blood group typing solutions in hospitals and emergency response units
• Government initiatives and investments aimed at strengthening blood transfusion services and expanding healthcare infrastructure are further supporting the adoption of advanced blood typing technologies globally
• Furthermore, the growing focus on strengthening blood bank infrastructure and national blood donation programs is making blood typing an integral component of healthcare delivery systems, ensuring availability of safe and compatible blood units
• The increasing adoption of advanced diagnostic technologies, combined with the need for rapid and precise results in emergency and surgical settings, is propelling the demand for automated blood typing systems across hospitals and laboratories. The shift towards digitized healthcare systems and improved laboratory workflows further contributes to market growth

Restraint/Challenge

“High Cost of Advanced Systems and Regulatory Compliance Hurdle”

• Concerns surrounding the high cost of advanced automated and molecular blood typing systems, along with stringent regulatory requirements, pose a significant challenge to broader market adoption. As these technologies require substantial investment and validation, smaller laboratories may face financial and operational barriers
• For instance, strict regulatory frameworks for diagnostic devices in regions such as North America and Europe require extensive clinical validation and approvals, increasing time-to-market for new products and limiting rapid adoption
• Addressing these cost and compliance challenges through technological innovation, cost optimization, and streamlined regulatory pathways is crucial for market expansion. Companies such as QuidelOrtho Corporation emphasize the development of cost-effective and compliant solutions to enhance accessibility. Additionally, the need for skilled professionals to operate advanced systems can act as a barrier, particularly in developing regions with limited trained workforce
• While technological advancements are improving efficiency, the high upfront investment and operational complexity can still hinder widespread adoption, especially in resource-constrained healthcare settings
• Limited access to advanced diagnostic technologies in low- and middle-income countries remains a key barrier, restricting the widespread adoption of automated and molecular blood typing solutions
• Overcoming these challenges through increased funding for healthcare infrastructure, training programs for laboratory personnel, and the development of affordable diagnostic solutions will be vital for sustained market growth

Blood Group Typing Market Scope

The market is segmented on the basis of product and services, technique, test type, and end-user.

• By Product and Services

On the basis of product and services, the blood group typing market is segmented into consumables, instruments, and services. The consumables segment dominated the market with the largest market revenue share of 45.7% in 2025, driven by their continuous and repetitive usage in routine blood typing and screening procedures across hospitals and blood banks. Reagents, antisera, and test kits are essential for every test conducted, leading to consistent demand irrespective of testing volume fluctuations. The increasing number of blood donations, transfusions, and diagnostic procedures further supports the dominance of this segment. Additionally, advancements in reagent formulations and ready-to-use kits have enhanced accuracy and reduced processing time, boosting adoption. The widespread availability and cost-effectiveness of consumables compared to instruments also contribute to their leading position. Growing focus on safety and quality control in transfusion practices further accelerates the demand for high-quality consumables globally.

The instruments segment is anticipated to witness the fastest growth rate during the forecast period, fueled by the increasing adoption of automated and high-throughput diagnostic systems in laboratories. Automated blood typing analyzers improve efficiency, minimize human error, and enable large-scale sample processing, making them highly attractive for modern healthcare facilities. Rising investments in laboratory infrastructure and digital healthcare transformation are also driving the adoption of advanced instruments. Furthermore, integration with laboratory information systems enhances workflow management and data accuracy. The shift toward automation in emerging economies is further contributing to segment growth. Continuous technological advancements and the introduction of compact, user-friendly systems are expected to strengthen demand for instruments.

• By Technique

On the basis of technique, the blood group typing market is segmented into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing, and other techniques. The assay-based techniques segment dominated the market with the largest market revenue share in 2025, owing to its widespread use in conventional blood typing methods such as agglutination and serological testing. These techniques are well-established, cost-effective, and widely adopted across healthcare facilities globally. Their simplicity and reliability make them the preferred choice for routine testing in blood banks and hospitals. Additionally, minimal training requirements and ease of implementation further strengthen their dominance. The high volume of routine blood grouping tests conducted daily significantly contributes to this segment’s leading share. Continuous improvements in assay sensitivity and specificity also enhance their clinical utility.

The massively parallel sequencing segment is expected to witness the fastest CAGR during the forecast period, driven by its ability to provide highly detailed genetic information for precise blood group determination. This advanced technique enables identification of rare blood group variants and complex antigen profiles that are difficult to detect using conventional methods. Increasing demand for precision medicine and personalized transfusion practices is fueling its adoption. Furthermore, technological advancements and decreasing sequencing costs are making this method more accessible. Growing research activities and applications in complex transfusion cases are also supporting its growth. The ability to deliver highly accurate and comprehensive results positions massively parallel sequencing as a key future growth driver.

• By Test Type

On the basis of test type, the blood group typing market is segmented into antibody screening, HLA typing, ABO blood tests, cross-matching tests, and antigen typing. The ABO blood tests segment dominated the market with the largest market revenue share in 2025, driven by its fundamental role in determining blood compatibility for transfusions. ABO testing is the most basic and mandatory step performed before any blood transfusion or surgical procedure, leading to its high volume of usage globally. The simplicity, speed, and cost-effectiveness of ABO testing contribute to its widespread adoption. Additionally, it is routinely conducted in hospitals, diagnostic laboratories, and blood banks, further strengthening its dominance. Increasing surgical procedures and emergency cases also drive demand for ABO testing. Continuous improvements in rapid testing kits have enhanced efficiency and reliability.

The HLA typing segment is anticipated to witness the fastest growth rate during the forecast period, fueled by the rising demand for organ transplantation and stem cell therapies. HLA typing is crucial for matching donors and recipients to minimize rejection risks and improve transplant outcomes. Increasing prevalence of chronic diseases and growing awareness about transplantation procedures are supporting segment growth. Furthermore, advancements in molecular typing technologies are enhancing the accuracy and speed of HLA testing. Rising investments in transplant infrastructure and research activities are also contributing to its expansion. The growing need for precision diagnostics in immunology further accelerates adoption.

• By End-User

On the basis of end-user, the blood group typing market is segmented into hospitals, clinical laboratories, blood banks, and others. The hospitals segment dominated the market with the largest market revenue share in 2025, driven by the high volume of surgical procedures, emergency treatments, and inpatient care requiring blood transfusions. Hospitals serve as primary centers for diagnosis and treatment, making them key users of blood typing services. The availability of advanced diagnostic infrastructure and skilled professionals further supports their dominance. Additionally, increasing patient admissions and rising healthcare expenditure contribute to higher testing volumes. Integration of automated systems in hospital laboratories enhances efficiency and accuracy. Continuous demand for immediate and reliable results in critical care settings strengthens this segment’s leading position.

The blood banks segment is expected to witness the fastest CAGR during the forecast period, driven by the increasing focus on safe blood collection, storage, and distribution. Blood banks require continuous blood typing and screening to ensure compatibility and safety of stored blood units. Growing awareness about voluntary blood donation and government initiatives to strengthen blood bank infrastructure are supporting segment growth. Furthermore, adoption of advanced testing technologies in blood banks enhances operational efficiency and traceability. Rising demand for blood components in trauma and chronic disease management further boosts growth. Expansion of centralized blood bank networks is also contributing to increased adoption of advanced blood typing solutions.

Blood Group Typing Market Regional Analysis

• North America dominated the blood group typing market with the largest revenue share of 38.5% in 2025, characterized by advanced healthcare infrastructure, high adoption of automated diagnostic technologies, and a strong presence of key industry players
• Healthcare providers in the region highly value the accuracy, efficiency, and automation offered by modern blood typing solutions, along with their integration into laboratory information systems and transfusion management workflows
• This widespread adoption is further supported by advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of key market players, establishing blood group typing systems as a critical component in hospitals, clinical laboratories, and blood banks

U.S. Blood Group Typing Market Insight

The U.S. blood group typing market captured the largest revenue share of 81% in 2025 within North America, fueled by the strong demand for safe blood transfusion practices and the widespread adoption of advanced diagnostic technologies. Healthcare providers are increasingly prioritizing accuracy and efficiency in blood typing to support surgical procedures and emergency care. The growing preference for automated systems, combined with robust demand for high-throughput testing and integrated laboratory solutions, further propels the market. Moreover, the increasing implementation of advanced immunohematology technologies and digital laboratory infrastructure is significantly contributing to the market's expansion.

Europe Blood Group Typing Market Insight

The Europe blood group typing market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by stringent healthcare regulations and the rising need for safe and efficient transfusion services. The increase in chronic diseases and surgical procedures, coupled with the demand for advanced diagnostic technologies, is fostering the adoption of blood typing solutions. European healthcare providers are also drawn to the accuracy and reliability these systems offer. The region is experiencing significant growth across hospitals, clinical laboratories, and blood banks, with blood typing technologies being incorporated into both routine diagnostics and specialized testing applications.

U.K. Blood Group Typing Market Insight

The U.K. blood group typing market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by the increasing demand for reliable diagnostic services and a focus on improving patient safety. Additionally, concerns regarding transfusion-related complications are encouraging healthcare providers to adopt advanced blood typing solutions. The UK’s emphasis on modernizing healthcare infrastructure, alongside its robust diagnostic ecosystem, is expected to continue to stimulate market growth.

Germany Blood Group Typing Market Insight

The Germany blood group typing market is expected to expand at a considerable CAGR during the forecast period, fueled by increasing awareness of advanced diagnostic technologies and the demand for efficient healthcare solutions. Germany’s well-developed healthcare infrastructure, combined with its emphasis on innovation and quality, promotes the adoption of blood typing systems, particularly in hospitals and laboratories. The integration of automated diagnostic platforms is also becoming increasingly prevalent, with a strong preference for accurate and standardized testing aligning with local healthcare requirements.

Asia-Pacific Blood Group Typing Market Insight

The Asia-Pacific blood group typing market is poised to grow at the fastest CAGR of 10.5% during the forecast period of 2026 to 2033, driven by increasing healthcare expenditure, rising awareness about blood safety, and expanding diagnostic infrastructure in countries such as China, Japan, and India. The region's growing focus on improving healthcare access, supported by government initiatives promoting blood donation and screening programs, is driving the adoption of blood typing solutions. Furthermore, as Asia-Pacific strengthens its healthcare systems, the accessibility and availability of advanced diagnostic technologies are expanding to a wider population base.

Japan Blood Group Typing Market Insight

The Japan blood group typing market is gaining momentum due to the country’s advanced healthcare system, aging population, and increasing demand for precise diagnostic solutions. The Japanese market places a significant emphasis on patient safety, and the adoption of blood typing technologies is driven by the rising number of surgical procedures and transfusion requirements. The integration of automated systems with laboratory workflows is fueling growth. Moreover, Japan's focus on technological innovation is likely to spur demand for highly accurate and efficient blood typing solutions in both clinical and research settings.

India Blood Group Typing Market Insight

The India blood group typing market accounted for the largest market revenue share in Asia Pacific in 2025, attributed to the country's expanding healthcare infrastructure, rising awareness about blood donation, and increasing prevalence of chronic diseases. India stands as one of the fastest-growing markets for diagnostic services, and blood typing is becoming increasingly essential in hospitals, blood banks, and laboratories. The push towards improving healthcare accessibility and government initiatives supporting blood safety programs, alongside the availability of cost-effective diagnostic solutions, are key factors propelling the market in India.

Blood Group Typing Market Share

The Blood Group Typing industry is primarily led by well-established companies, including:

• Bio-Rad Laboratories, Inc. (U.S.)
• Grifols, S.A. (Spain)
• QuidelOrtho Corporation (U.S.)
• Immucor, Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Abbott (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Siemens Healthineers AG (Germany)
• BD (U.S.)
• Beckman Coulter, Inc. (U.S.)
• Merck KGaA (Germany)
• Quotient Limited (Switzerland)
• DIAGAST SAS (France)
• AXO Science SAS (France)
• Tulip Diagnostics (P) Ltd. (India)
• Fujirebio Holdings, Inc. (Japan)
• DiaSorin S.p.A. (Italy)
• BAG Diagnostics GmbH (Germany)
• Rapid Labs Ltd. (U.K.)
• Agena Bioscience, Inc. (U.S.)

What are the Recent Developments in Global Blood Group Typing Market?

• In December 2025, a research publication on MedRxiv identified over 80 commercially available or late-stage point-of-care blood testing devices, reflecting rapid innovation in decentralized diagnostics. These advancements are enabling faster and more accessible blood typing and screening solutions, particularly in emergency and remote healthcare settings, thereby strengthening global transfusion infrastructure
• In October 2025, Grifols announced expansion of its blood typing diagnostics production capacity in the U.S. to meet rising global demand. The company reported strong double-digit growth in its diagnostics division, reflecting increasing adoption of advanced blood typing technologies and strengthening transfusion infrastructure worldwide
• In November 2024, a Blood market expansion driven by hospitals and blood banks reported that major diagnostic companies such as Abbott, Bio-Rad, and Grifols are increasingly integrating AI-powered technologies into blood testing and typing workflows. These advancements are improving diagnostic efficiency and supporting the growing demand for safe transfusion practices across hospitals and blood banks globally
• In April 2024, Grifols highlighted the critical role of accurate blood typing in transfusion safety, organ transplantation, and clinical diagnostics. The article emphasized increasing reliance on validated, FDA-approved blood typing reagents and systems to ensure patient safety and compatibility in healthcare settings
• In March 2023, MedGenome Labs announced the launch of its new FSHD1 genetic screening test in India, expanding its portfolio of advanced diagnostic services. This development highlights the growing adoption of molecular and genetic testing technologies, which are increasingly being applied in blood typing and immunohematology for improved diagnostic accuracy and early disease detection

SKU-23929